A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant

We report on a prospective phase II trial of 32 patients who underwent unrelated donor hematopoietic cell transplantation, with a tacrolimus, sirolimus and rabbit anti-thymoctye globulin GVHD prophylactic regimen. The primary study endpoint was incidence of grades II-IV acute GVHD, with 80% power to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaled, Samer K., Palmer, Joycelynne, StillerMS, Tracey, Senitzer, David, Maegawa, Rodrigo, Rodriguez, Roberto, Parker, Pablo M., Nademanee, Auayporn, Cai, Ji-Lian, Snyder, David S., Karanes, Chatchada, Osorio, Edna, Thomas, Sandra H., Forman, Stephen J., Nakamura, Ryotaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566319/
https://www.ncbi.nlm.nih.gov/pubmed/23000644
http://dx.doi.org/10.1038/bmt.2012.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566319/
https://www.ncbi.nlm.nih.gov/pubmed/23000644
http://dx.doi.org/10.1038/bmt.2012.175

Ejemplares similares